Digitoxigenin mono-β-D-digitoxoside

CAS : 18404-43-8

Ref. 3D-TAA40443

Informations sur le produit

• Nom: Digitoxigenin mono-β-D-digitoxoside
• Marque: Biosynth
• Description: Digitoxigenin mono-β-D-digitoxoside is a potent inhibitor of tumor growth and cancer cell proliferation. It is an analog of the cardiac glycoside digitoxin, which is known for its anticancer properties. Digitoxigenin mono-β-D-digitoxoside has been shown to induce apoptosis in human cancer cells by inhibiting protein kinases such as AKT and ERK1/2. This drug also has potential therapeutic applications in the treatment of ghrelin-related diseases, as it has been shown to inhibit the activity of ghrelin, a hormone that stimulates appetite and promotes weight gain. Additionally, digitoxigenin mono-β-D-digitoxoside exhibits high water solubility due to its cellulose-based structure, making it ideal for use in urine-based diagnostic tests for cancer detection.

Propriétés chimiques

• Masse moléculaire: 504.7 g/mol
• Formule: C₂₉H₄₄O₇
• Degré de pureté: Min. 95%